Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Canax logo — Società specializzata nello sviluppo di prodotti cosmeceutic...

Canax

Società specializzata nello sviluppo di prodotti cosmeceutici e nutraceutici con estratti naturali in CO2 supercritica

Founded 2019 Italy Italy 4 employees Debt Financing Total: $2.50M Biotechnology, Health Care +1

General Information

Company Name Canax
Founded Year 2019
Location Italy Italy
Employees 4
Industries Biotechnology, Health Care, Pharmaceutical
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with Canax. To contact Canax, visit canax.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Canax compare?

A PDF of Canax and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Canax soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Canax

Canax is an Italian company specializing in extraction through supercritical CO2 and purification of compounds derived from cannabis. Founded in 2019, the company utilizes the most modern technologies and a deep understanding of the subject to extract 99.9x% pure isolated CBD for pharmaceutical, cosmetic, food, and veterinary use. The company's slogan "Società specializzata nello sviluppo di prodotti cosmeceutici e nutraceutici con estratti naturali in CO2 supercritica" highlights its focus on the development of cosmeceutical and nutraceutical products with natural extracts through supercritical CO2 extraction. Canax operates in the Biotechnology, Health Care, and Pharmaceutical industries, with its headquarters based in Italy. Canax recently secured a €1.25M Debt Financing investment on 16 March 2022. The identity of the investors involved in the latest funding round is currently undisclosed. With its innovative approach to cannabis-derived compounds and the growing market demand for natural-based pharmaceutical and cosmetic products, Canax stands at the forefront of the industry. This recent investment further propels the company's potential for expansion and development in the health and wellness sector.

Business keywords: CBD products, pharmaceutical industry, cosmeceutical industry, CO2 supercritical extraction, Cannabis extracts, pharmaceutical use, cosmetic use, veterinary use, CO2 extraction specialist, Cannabis-derived pharmaceuticals, Hemp extracts, plant-derived extracts, phytotherapeutic formulations, chemistry, supercritical CO2

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing €1.25M -
16 Mar 2022
Seed Round €1.25M -
03 Sep 2021

Canax Alternatives & Competitors

View All Alternatives
Canax vs
Hempika
Hempika Slovenia

Organic • Certified • Made in EU • Since 2015

1 employees
Biotechnology, Food and Beverage
Canax vs
IGEA Pharma N.V.
IGEA Pharma N.V. The Netherlands

Harnessing the wealth of nature and innovative technologies to improve human health

Post-IPO Debt
2-10 employees
Biotechnology, Health Care
Canax vs
West-Coast Pharma
West-Coast Pharma India

Our experience and dedication makes us capable of processing all kinds of effective medicinal produc...

20 employees
Health Care, Manufacturing
View all alternatives

FAQ About Canax

Società specializzata nello sviluppo di prodotti cosmeceutici e nutraceutici con estratti naturali in CO2 supercritica
Canax was founded in 2019.
Canax is headquartered in Italy.
Canax operates in Biotechnology, Health Care and Pharmaceutical. Its work centres on CBD products, pharmaceutical industry, cosmeceutical industry and CO2 supercritical extraction.
Canax has approximately 4 employees.
Canax has completed 2 funding rounds, raising a total of $2.50M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Canax include Hempika, IGEA Pharma N.V., West-Coast Pharma, Má Botanics, Avicanna Inc. (TSX:AVCN). These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Canax and Hempika are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Canax, https://bouncewatch.com/company/canax, updated 24 October 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout